3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
5
Phase 2
5
Phase 4
4
Phase 3
2
Phase 1/2
1
Phase 1
1
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Carcinoma, Hepatocellular
10
Liver Neoplasms
2
Thyroid Nodule
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Hyperthyroidism
1
Hypertension, Portal
1
Colorectal Neoplasms
1
Interventions
Sorafenib
8
durvalumab
4
Cisplatin
4
Gemcitabine
3
Ethiodized Oil
3
Doxorubicin
3
Chemotherapy, Adjuvant
3
Bevacizumab
3
tremelimumab
2
sodium thiosulfate
2
phosphomannopentaose sulfate
2
Watchful Waiting
2
Talaporfin
2
Radiofrequency Ablation
2
Oxaliplatin
2
Nivolumab
2
Folfox protocol
2
Celecoxib
2
Capecitabine
2
Analgesia, Patient-Controlled
2
seocalcitol
1
parecoxib
1
nolatrexed
1
linifanib
1
lenvatinib
1
ferumoxides
1
ferric carboxymaltose
1
contrast agent BR1
1
cabozantinib
1
brivanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Liver Neoplasms
×
Radiofrequency Ablation
×
Clear all
NCT02192671
2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3
Unknown
120 enrolled
NCT02169765
2020-07-22
ARTC-HCC
Guangxi Medical University
Phase 3
Unknown
120 enrolled